Acute post-COVID-19 infection increases the risk of new-onset autoimmune disease
According to a recent study published in Clinical Rheumatology, patients with COVID-19 have a 43% higher chance of developing new autoimmune disorders in the 3 …
According to a recent study published in Clinical Rheumatology, patients with COVID-19 have a 43% higher chance of developing new autoimmune disorders in the 3 …
Recently, a novel dietary strategy known as the Very Low-Calorie Ketogenic Diet (VLCKD) has been proposed as a viable treatment option for certain disorders that …
According to studies published in The Lancet Rheumatology, people with hip or knee osteoarthritis (OA) who exercise fare better than patients who do not, thereby …
A small protein called CD24, which is glycosyl-phosphoinositol-anchored and sends T cells costimulatory signals, has been linked to the onset of autoimmune illness. According to …
A novel non-antibody biological CD40L antagonist named dazodalibep is currently under investigation as a potential therapy for autoimmune diseases. The results of the phase 2 …
According to research published in Rheumatology, nintedanib reduces the decline of lung functionality in patients with limited cutaneous systemic sclerosis (SSc) and interstitial lung disease …
According to a recent study published in Frontiers in Immunology, the combination of tofacitinib and iguratimod is superior to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) …
According to data published in Arthritis Care & Research, the introduction of tumor necrosis factor inhibitors (TNFi) in 2003 was not successful in preventing fracture …
A multidisciplinary strategy, comprising physical exercise therapy, occupational therapy, patient self-management, and pharmaceutical therapy, is necessary for the ideal care of rheumatoid arthritis (RA). According …